Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States
Publication
, Conference
Lee, CJ; Hellewell, EM; Ng, K; Gooley, T; Sung, AD; Taylor, AO; Hong, S; Ahmed, N; Morey, C; Fitzmaurice, S; Kennedy, VE; Lauer, M; Trunk, AD ...
Published in: Blood
November 5, 2024
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
2170 / 2170
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lee, C. J., Hellewell, E. M., Ng, K., Gooley, T., Sung, A. D., Taylor, A. O., … Bhatt, N. (2024). Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. In Blood (Vol. 144, pp. 2170–2170). American Society of Hematology. https://doi.org/10.1182/blood-2024-210263
Lee, Catherine J., Elizabeth M. Hellewell, Kevin Ng, Ted Gooley, Anthony D. Sung, Allison O. Taylor, Sanghee Hong, et al. “Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States.” In Blood, 144:2170–2170. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-210263.
Lee CJ, Hellewell EM, Ng K, Gooley T, Sung AD, Taylor AO, et al. Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. In: Blood. American Society of Hematology; 2024. p. 2170–2170.
Lee, Catherine J., et al. “Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 2170–2170. Crossref, doi:10.1182/blood-2024-210263.
Lee CJ, Hellewell EM, Ng K, Gooley T, Sung AD, Taylor AO, Hong S, Ahmed N, Morey C, Fitzmaurice S, Kennedy VE, Lauer M, Trunk AD, Hamilton BK, Sharma A, Phelps-Bergeron Z, Hill L, Faramand R, Liu H, Winestone LE, Cheng G, Espinoza-Gutarra M, Jamy O, Odstrcil Bobillo M, McClune B, Nawas MT, Yates SJ, Nishitani M, Takahashi T, Koo J, Myers K, Mahadeo KM, Bauchat A, Pearson LK, Walia R, Seago K, Yingling S, Edgar C, Browning A, Bhatt N. Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. Blood. American Society of Hematology; 2024. p. 2170–2170.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
2170 / 2170
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology